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The accuracy of our lactate dehydrogenase (EC 1.1.1.27) isoenzyme procedure, based on electrophoresis in thinlayer agarose, has previously been assessed (Clln. Chem. 22:1995, 1976 ). We now show that the method is similarly accurate and precise for the specific measurements of lactate dehydrogenase isoenzyme-1 and -2. We have also determined the lactate dehydrogenase isoenzyme pattern
In peripheral erythrocytes and have found that lactate dehydrogenase-1 is usually the isoenzyme present in eatest concentration. Therefore, hemotysis may increase lactate dehydrogenase-1 in serum, affecting the lactate dehydrogenase isoenzyme ratio used in the diagnosis of myocardial infarction. This conjecture has been confirmed by in vitro experiments, and in a small group of patients with intra-vascular hemolysis.
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Erythrocytes are rich in lactate dehydrogenase (LD; Llactate: NAD oxidoreductase; EC 1.1.1.27) isoenzymes 1 and 2 (1) . Hemolysis, whether occurring intravascularly or during sample collection orpreparation, cantherefore introduce these isoenzymesintothe serum and distort the serum LD isoenzyme pattern.The extentof thisdistortion iscurrentlya matter ofdebate.RecentlyLottand Stang (2) suggested, as a result of theirexperimentalwork,thatinvitrohemolysis alonewill notproduce flipping' oftheserum LD-1/LD-2 ratio because erythrocyte LD-2 exceeds LD-1. Cembrowski (3) asserted, on the basisof a literature review,thatthereare many hematological diseases in which erythrocyte LD-1> LD-2 and that when hemolysis occurs in these conditions, serum LD-1 may equal, or exceed, LD-2.
Clearly, the answer to this dispute is of considerable significance. If it can be established, beyond all doubt, that hemolysis alone cannot cause serum LD-1 activities to exceed LD-2, then there will be fewer falsely positive results due to hemolysis, e.g., in suspected myocardial infarction where flipping of LD-1 is common.
We believe that the current dispute is based on a logical fallacy. Arguments about the relative magnitude of LD-1 and LD-2 values can be resolved only if it is known that the isoenzyme method used is known to accurately measure LD-1 and LD-2. Accuracy is defined as the agreement between the best estimate of a quantity and its true value, whereas precision is the agreement between replicate measurements (4) .
No reliable conclusions can be drawn about LD-1 and LD-2 (6) .
The LD isoenzymesfrom the serum and the erythrocytes were separated by electrophoresis on thin-layeragarose (5).
The NADH fluorescence that developed over the LD isoenzymes (5) on the gel was recorded with a densitometer (Clini-Scan; Helena Laboratories, Beaumont, TX 77704). Isoenzyme purification.
LD-1 and LD-2 were purified as previously described (7, 8) . The homogeneity of the fractions was established by thin-layer electrophoresis on agarose.
Isoenzyme preparations.
Allisoenzyme preparations were suspended in 160 mmol/L NaCI containing 35 g of human albumin (PentexHuman Albumin, Cohn FractionV; Miles Laboratories Inc., Elkhart,IN 46515).However, we subsequently showed that results obtainedfrom substrateoptimization, orfrom electrophoresis, wereunaffected by omitting the albumin from thesaline solutions.
Reference ranges for serum. The reference interval fortotal LD in serum is203 to 378 U/L. The serum LD isoenzyme ranges,as percentageoftotalactivity, are 14-26%, 29-39%, 20-26%,8-16%,and 6-16% forLD-1 toLD-5,respectively. The LD-1/LD-2 isoenzyme ratio established previously for 250 normal subjects ranges between 0.45 and 0.74 (9) .
Results
Optimizing conditions.
The LD-1 and LD-2 preparations from erythrocytes were uncontaminated by any other LD isoenzyme, yieldingsinglebands upon electrophoresis. The isolated isoenzymes had initial activities as great as 1600 U/L.
Theoptimum concentration
of pyruvate for the assay was 1.2 and 1.3 mmolfL for LD-1 and LD-2, respectively; however, a common substrate concentration of 1.2 mmolfL is acceptable for both isoenzymes.Each isoenzymepreparation wasassayed 20 times by the reaction-rate method; CVs were 5.5 and 5.1% for LD-1 and LD-2, respectively. The "true" value (i.e., the assigned value) for LD-1 and LD-2 activity in each preparation was assumed to be the mean value of these assay results.
Precision of the LD isoenzyme assays. The routinebetween-batch precision of the LI) isoenzyme assay (as standard Total ID actMties applied totheplate were such as to obviate sobstrate depletion during the incubation In all cases, LD-5 was undetectable in these hemolysates. The LD-1/LD-2 ratioin these two groups were comparable and reflected the similarity of the LD-1 and LD-2 isoenzyme mean values. The LD activity in the hemolysates was determined in relationship to the amount of hemoglobin measured. The patient population gave a slightly lower value for mean erythrocyte LD activity, 215 (SD 36) vs 239 (SD 26) U/g of hemoglobin, but therangeoverlappedwith that for the group of healthy subjects.
Effect of storage on hemolysate LD isoenzymes.
Storage ofhemolysatesatroom temperaturemarkedly changesthe LD-1/LD-2 ratios (Figure 2 ). To obviate artefactual effects in our experiments due to this cause, we conducted all experiments with fresh hemolysates, including those yielding the data reported in Table 1 .
Effect of addition of hemolysates to normal serum. When
theLD1-ILD-2 ratio of the hemolysate is <1, addition of this material to normal serum will never cause flipping of the resulting pattern (Figure 3 ) The LD-1/LD-2 ratio of the serum, initially 0.64 (i.e., normal) increased progressively from 0.75 (0.5 g/L hemoglobin) to 0.98(16 g/L hemoglobin). These ratios exceed the upper reference limit of 0.74 that we established for a healthy population (9) . Addition of a hemolysate with an LD-1/LD-2 ratio >1 to a normal serum (LD-1/LD-2 = 0.65) will create a flipped pattern above a hemoglobin concentration of 8 g/L (Figure 4) . The equivalent LD-1ILD-2 ratios are correspondingly higher than those obtained from Figure 3 .
Discussion
We used homogeneous isoenzyme preparationsof LD-1 and LD-2 derived from human erythrocytes to demonstrate that the procedure based on thin-layerelectrophoresisin agarose is an accurate method for assessing both the individual concentration of these isoenzymes and the LD-1/LD-2 ratio. The Our results ( Table 1 ) also demonstrate that most specimens of peripheral erythrocytes have LD-1 > LD-2. There appears to be no difference between our patient population and the group of healthy laboratory staff in this respect. Presumably, the variations observed ineach population reflect the different stages of development and maturation of the erythrocytes (3, 11, 12) . We did not detectLD-5. Othershave attributed the presence ofLD-5 to the presence of granubocytes, which have a preponderanceof LD-5 (12), or to the medium used to prepare the hemolysate(1). In Table 2 we havelisted thefmdings of other workerswho used a variety of separation media. In the light oftheproven accuracyof our procedure we believe thatour determinations are likely to be more definitive than the reports ofothers.
Another source of possiblevariability in assessingthe consequencesof hemolysis is the innatestability of the isoenzyme inthehemolysate. Kreutzerand Fennis (13) studied the stability of the LD isoenzymes in serum at different temperatures(buttheir studydidnot include thestability of the isoenzymesin hemolysates). Lott and Stang (2) reported similar results from theirstudies ofserum afterstorageat25 and 4 #{176}C. Starkweatheret al.
(1) used erythrocytes removed atintervals from bloodstored at4#{176}C and foundthattherewas a proportionate increase inLD-1 over a 60-day period. Our study was restricted tostorageofhemolysate isoenzymesat room temperaturebecause we could find no reports on the results ofsuch storage. As shown in Figure2, an in-patient sample gaveLD-1/LD-2 ratios of0.78, 0.92, 1.12,2.05, and 2.17 after storage atroom temperature for one, two,three, six, and nine days,respectively. The unwary may be lulled intoa sense offalse security by the reassuring (and quitecorrect) statement by Lott and Stang (2) thatserum isoenzyme patterns are stable atroom temperaturefor48 h.Clearly, thisadmo- nition does not apply to the LD isoenzyme patterns in hemolysis. It is evident that fresh hemolysate must be used to avoid artefactual elevations of LD-1. But even if the problems created by undue storage of a hemolysate are circumvented, we believe that it is important to establish the actual LI) isoenzyme pattern of the hemolysate before adding it to serum when the influence of hemolysis on serum LD isoenzyme patterns is being investigated. This is evident from an examination of Figures 3 and 4 . If both the pre-existing serum and hemolysate have LD-1/LD-2 ratios <1 then the resulting ratio can never exceed1, although itwill certainly beincreased above the upper reference limit of 0.74 (9) . If the hemolysate ratio is >1 (which is more probable-see Table 1 ) then the resulting ratio will flip if there is sufficient hemolysis. These conjectures are further supported by our fmdings on six recent casesof proven intra-vascular hemolysis. Of six patients, three had ratios >1(1.01, prosthetic heart valve; 1.05, methyldopa-induced hemolysis; 1.26, newly diagnosed pernicious anemia) and three had not (0.87, thrombocytopenic purpura; 0.88, sideroblastic anemia; 0.92, hereditary spherocytosis). Unfortunately, Lott and Stang in their authoritative review (2) have not taken account of the possibility that erythrocyte LD-1/LD-2 ratios may vary widely. Also they have been misled by reports that LD-1 is less than LD-2 in erythrocytes. If an accurate method is used this claim is readily shown to be false.
In summary, therefore, we assert that when the endogenous content of erythrocyte LD isoenzymesis taken into account, hemolysis can cause flipping of the LD-1ILD-2 ratio, if an accurate procedure is used. In addition, we make a plea for LD isoenzyme studies of tissues and sera with use of an accurate methodology so that many of the earlier, inaccurate, quantitations can be replaced with more reliable data.
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